LINCOLN, NE—National Research Corporation (NASDAQ:NRC), a leader in commercial physical and biological research, announced the upcoming retirement of Linda Stacy, who has served as Secretary, Principal Financial (NASDAQ:PFG) Officer, and Principal Accounting Officer. Stacy, who has been with the company for over 18 years, will retire on December 31, 2024.
The announcement was made in a filing with the Securities and Exchange Commission on November 8, 2024, and was formally filed on Thursday. The company's Board of Directors expressed their gratitude to Stacy for her long-standing contribution to the firm's growth and success.
Stacy's departure marks the end of a significant era for National Research Corporation, which is incorporated in Delaware and headquartered in Lincoln, Nebraska. The company has not yet announced a successor for Stacy's position. This transition comes at a time when the company continues to navigate the competitive landscape of the research industry.
National Research Corporation has a history of providing services within the commercial physical and biological research sector, and Stacy's role has been pivotal in overseeing the financial and accounting operations within the company.
Hrdy's extensive experience with National Research Corporation, spanning over two decades, has seen her rise through the ranks. Her previous roles have positioned her at the forefront of customer relations and growth initiatives, key areas that are likely to be under her purview as COO. This appointment comes as National Research Corporation continues to focus on enhancing its research services and expanding its market reach.
InvestingPro Insights
As National Research Corporation prepares for Linda Stacy's retirement, investors may find value in examining the company's financial health and market performance. According to InvestingPro data, NRC's market capitalization stands at $460.37 million, with a price-to-earnings ratio of 17.35, suggesting a moderate valuation relative to earnings.
Despite the upcoming leadership change, NRC has demonstrated financial stability. An InvestingPro Tip highlights that the company has raised its dividend for 3 consecutive years, indicating a commitment to shareholder returns. This is further supported by the current dividend yield of 2.37%, which may be attractive to income-focused investors.
The company's profitability is also noteworthy, with a gross profit margin of 60.89% for the last twelve months as of Q3 2024. This robust margin suggests NRC maintains strong pricing power in its niche within the commercial physical and biological research sector.
For those interested in a deeper analysis, InvestingPro offers additional tips and metrics that could provide further context to NRC's financial position and future prospects. There are 5 more InvestingPro Tips available for NRC, which could be particularly valuable as the company navigates this leadership transition.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.